| abstract |
Compounds of formula X, wherein A, X, Y, Z, R 5 , R 6a and R 6b are as defined herein, and pharmaceutically acceptable salts thereof include humans Are useful for the treatment of cognitive deficits associated with schizophrenia and other neurodegeneration and / or neuropathy. [Selection] Figure 1 |